Doubling Down in APAC: Strategies for Pharma Growth

​Proudly presented by Geneo at Singapore Science Park and Biotech Connection Singapore

Doubling Down in APAC: Strategies for Pharma Growth 🚀

The Asia-Pacific (APAC) region is a strategic priority for global pharmaceutical companies, driven by rising healthcare needs, government investments, digital health innovation, and evolving patient expectations. From mature markets to emerging ones, companies are navigating complex regulatory environments, pricing pressures, and access challenges.

💬 How are leading pharma players charting bold, patient-centric growth in APAC?
💬 What does it take to deliver meaningful impact across these dynamic healthcare landscapes?

🎯 Join us for an evening of strategic insights and high-impact dialogue as we bring together an esteemed panel of senior industry leaders to share a 360° view of pharma growth in APAC.

🎙️ Opening Speaker & Moderator:
Fabio La Mola - Partner, APAC Healthcare & Life Sciences, Bain & Company

💡 Panel Speakers:
Dr Rajiv Rana, MD - Head of Medical Affairs, Asia Pacific, Merck Group
Evelyn Pang - General Manager, Moderna Singapore
Dr. Flora Ren - Senior Director, Strategy & PMO, Asia Pacific, Johnson & Johnson Innovative Medicine

​Programme

​5:00 PM – Registration
5:30 PM – Welcome Remarks
5:45 PM – Opening Presentation by Mr. Fabio La Mola
6:00 PM – Panel Discussion
7:00 PM – Networking
8:00 PM – Closing

​Whether you’re in pharma, biotech, medtech, healthcare strategy, or policy, this is a rare opportunity to hear from the region’s most influential healthcare leaders.

​Seats are limited—secure your spot early to avoid disappointment!